Abstract: Provided is a hybrid trusted execution environment based android security framework, an android device equipped with the same and a method of executing a trusted service in the android device. The hybrid trusted execution environment based android security framework includes a hardware resource that comprises a rich execution environment (REE) where an android operating system (OS) runs, and a secure container which implements a virtualized trusted execution environment (VTEE) that processes a security task in the rich execution environment (REE) when an application running on the rich execution environment requests the security task.

Abstract: Aspects relate to patterned nanostructures having a feature size not including film thickness of below 5 microns. The patterned nanostructures are made up of nanoparticles having an average particle size of less than 100 nm. A nanoparticle composition, which, in some cases, includes a binder material, is applied to a substrate. A patterned mold used in concert with electromagnetic radiation function to manipulate the nanoparticle composition in forming the patterned nanostructure. In some embodiments, the patterned mold nanoimprints a suitable pattern on to the nanoparticle composition and the composition is cured through UV or thermal energy. Three-dimensional patterned nanostructures may be formed. A number of patterned nanostructure layers may be prepared and suitably joined together. In some cases, a patterned nanostructure may be formed as a layer that is releasable from the substrate upon which it is initially formed.

Abstract: A delta-sigma modulator generates a bit stream signal from an analog signal by operating according to a modulation period including a sampling period and a filtering period and includes a digital-to-analog converter (DAC) configured to generate a charge signal according to one of a first reference voltage and a second reference voltage according to the bit stream signal during the sampling period and to output a signal generated according to the charge signal and the other of the first reference voltage and the second reference voltage; a loop filter configured to charge a sampling signal corresponding to the analog signal during the sampling period and to filter an output from the DAC and a signal generated according to the sampling signal during the filtering period; and a quantizer configured to generate the bit stream signal according to an output from the loop filter in the modulation period.

Abstract: The present invention includes compositions and methods of for treating plants infected with fungal pathogens by contacting an infected plant or plant at risk of infection with a fungicidal composition comprising an fungicide selected from copper compound such as copper octanoate or copper hydroxide, or a triazole fungicide such as myclobutanil, propiconazole, tebuconazole or epoxiconazole, an enhancer selected from apyrase inhibitors, e.g., N-(m-tolyl)-[1, 1?-biphenyl]-4-sulfonamide, S-heptyl 2-oxo-2H-chromene-3-carbothioate, 3-(N-(4-bromophenyl) sulfamoyl)-N-(3-nitrophenyl) benzamide, or (E)-3-methyl-N-(1-(naphthalen-2-yl) ethylidene) benzohydrazide and, optionally, a phytologically-acceptable inert carrier.

Abstract: Various autonomous aquatic herbicide application vessels are described. In one embodiment, a system for aquatic herbicide application includes an aquatic vessel, a propulsion system to propel the aquatic vessel over a body of water, a holding container to hold a substance, a substance applicator to apply the substance to the body of water, and a controller. The controller can include a control processor configured to navigate the aquatic vessel using the propulsion system and apply the substance to the body of water using the substance applicator. According to one embodiment, the system includes a global positioning system to determine a geographic location of the system and a memory to store a route for application of the substance in the body of water. Further, the controller is configured to autonomously control the propulsion system to track the route based on changes in the geographic location of the system over time.

Abstract: An ankle-foot prosthesis includes a foot plate, an ankle frame attached to the foot plate, a yoke pivotally connected to the ankle frame and including a member for attaching to a leg, a damper having a first end connected to the yoke and a second end connected to the ankle frame, and a control mechanism for switching the damper between low and high settings.

Abstract: An electrical wire includes an aluminum element wire that has an aluminum base material and carbon nanotubes dispersed in the aluminum base material, in which the aluminum element wire has an electrical conductivity of 62% IACS or more and a tensile strength of 130 MPa or more. The aluminum base material is a polycrystal having a plurality of aluminum crystal grains. Further, a carbon nanotube conductive path, which is composed of the carbon nanotube, and forms a conductive path allowing electricity to conduct therethrough in a longitudinal direction of the aluminum element wire by being present in a part of grain boundaries between the plurality of aluminum crystal grains in a transverse cross section of the aluminum base material, and being present along the longitudinal direction of the aluminum element wire, is formed in the aluminum base material.

Abstract: Among the various aspects of the present disclosure is the provision of methods and compositions to treat or prevent an endoplasmic reticulum (ER) stress-mediated kidney disease in a subject, the method comprising administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of an ER calcium channel stabilizing agent or an ER stress modulating agent (e.g., mesencephalic astrocyte-derived neurotrophic factor (MANF), compound K201).

Abstract: To provide an individual boost circuit capable of boosting a minute power voltage to a target voltage more reliably. An individual boost circuit includes a first PMOS transistor that has a gate to which a first clock voltage is applied and performs on- and off-operations; a second PMOS transistor that has a gate to which a second clock voltage that has a reciprocal relation with the first clock voltage is applied and performs the on- and off-operations; an auxiliary capacitor; a boost capacitor; an auxiliary charging circuit 211 that charges an auxiliary capacitor via the second PMOS transistor with a power voltage from an external power when the first PMOS translator enters an off-state and the second PMOS transistor enters an on-state; and a boost charging circuit 212 that charges the boost capacitor via the first PMOS transistor with the second clock voltage through the auxiliary capacitor when the first PMOS transistor enters the on-state and the second switching transistor enters the off-state.

Abstract: The is provided a compound of formula I or II or physiologically acceptable salts or solvates, or oxidised derivatives thereof: where R1 to R3, R13 and R14 are as defined herein. Also disclosed herein are methods of dyeing hair or (temporarily) tattooing the skin using the compounds of formula I or II (or physiologically acceptable salts or solvates, or oxidised derivatives thereof) in a suitable composition.

Abstract: Provided herein are methods and compositions related to treating or preventing seizures. In some aspects, provided herein are methods of treating or preventing seizures in a subject by administering to the subject a composition comprising Parabacteroides and Akkermansia bacteria.

Abstract: A method of producing polycrystalline Y3Ba5Cu8Oy (Y-358) whereby powders of yttrium (III) oxide, a barium (II) salt, and copper (II) oxide are pelletized, calcined at 850 to 950° C. for 8 to 16 hours, ball milled under controlled conditions, pelletized again and sintered in an oxygen atmosphere at 900 to 1000° C. for up to 72 hours. The polycrystalline Y3Ba5Cu8Oy thus produced is in the form of elongated crystals having an average length of 2 to 10 ?m and an average width of 1 to 2 ?m, and embedded with spherical nanoparticles of yttrium deficient Y3Ba5Cu8Oy having an average diameter of 5 to 20 nm. The spherical nanoparticles are present as agglomerates having flower-like morphology with an average particles size of 30 to 60 nm. The ball milled polycrystalline Y3Ba5Cu8Oy prepared under controlled conditions shows significant enhancement of superconducting and flux pinning properties.

Abstract: The present disclosure provides compounds of any one of Formulae (I?), (I), (IA), (II?), (II), (IIA), (IIIA), (III?), (III?), (III), (IIIA), (IV), (V?), (V), (VI), (VII), (VIII?), (VIII), (IX?), (IX), and (X). The compounds described herein may be useful in treating and/or preventing a broad range of diseases (e.g., proliferative disease (e.g., cancers (e.g., non-small cell lung cancer, or glioma), inflammatory diseases, autoimmune diseases), CNS disorder (e.g., drug addiction), metabolic disorder (e.g., diabetes), or infectious disease (e.g., bacterial infection or parasitic infection (e.g., malaria))). Also provided in the present disclosure are pharmaceutical compositions, methods of synthesis of a compound described herein, kits, methods, and uses including or using a compound described herein.

Abstract: A sensing mechanism of a two-dimensional airfoil model, which includes pressure sensor groups, multiple first tubes, the second tube, and a cavity. The pressure sensor groups are vertically fixed to mounting holes in the surface of the two-dimensional airfoil model. The pressure measurement surface of each pressure sensor is vertical to the surface of the two-dimensional airfoil model. Multiple mounting holes are opened in and vertical to the surface of the two-dimensional airfoil model. The cavity is fixed to the interior of the two-dimensional airfoil model. The reference pressure end of each pressure sensor is connected to the cavity through the first tube, the multiple pressure sensors of the pressure sensor groups are in one-to-one correspondence with the multiple first tubes. The cavity is connected with the first end of the second tube. The second end of the second tube is located in the air outside the two-dimensional airfoil model.

Abstract: A method for detecting MERS-CoV at high sensitivity and specificity using IgY antibodies that bind to MERS-CoV N protein, its fragments and domains. Isolated or purified IgY monospecific antibodies to MERS-CoV N protein.

Abstract: A liquid crystal display device and a method of manufacturing a liquid crystal display device are provided. The liquid crystal display device includes: a base; an alignment inducing layer on the base and including a first compound represented by formula A1 or a polymer of the first compound; and a liquid crystal layer on the alignment inducing layer that includes liquid crystals: where R1 may be hydrogen or a polymerizable group, R2 may be a hydrophilic group, SP1 and SP2 may each independently be a single bond, a C1-C12 alkylene group, or a C1-C12 alkoxylene group, Z may be a single bond, an ester group, or an ether group, and X1, X2 and X3 may each independently be hydrogen, a methyl group, fluorine, or chlorine.

Abstract: Provided is a novel plant body comprising a plant tissue of a plant belonging to the family Solanaceae, Brassicaceae, Lamiaceae, or Orobanchaceae, wherein graft incompatibility is avoided or suppressed by using a graft medium between different-family plants.

Abstract: The present invention provides novel compounds with increased plasma stability that modulate PAR1 signaling, and methods of using them. The present invention provides methods of using the novel PAR1 modulators for the treatment of a number of disorders, including, inflammation, thrombosis, kidney disease, sepsis, stroke, as well as proliferation-related diseases. Furthermore, the PAR1 modulators of the present invention provide cytoprotection for certain cells and tissues, for example, in coronary blood vessels and tissues after a heart attack.

Abstract: Immunogenic compositions and prophylactic or therapeutic vaccines for use in protecting and treating against human cytomegalovirus (CMV) are disclosed. Subunit vaccines comprising a human CMV protein complex comprising pUL128 or pUL130, and nucleic acid vaccines comprising at least one nucleic acid encoding a CMV protein complex comprising pUL128 or pUL130 are described. Also disclosed are therapeutic antibodies reactive against a CMV protein complex comprising pUL128 or pUL130, as well as methods for screening compounds that inhibit CMV infection of epithelial and endothelial cells, methods for immunizing a subject against CMV infection, methods for determining the capability of neutralizing antibodies to inhibit CMV infection of cell types other than fibroblasts, and methods of diminishing an CMV infection.

Abstract: The present invention provides for a fusion protein comprising (1) a bacterial microcompartment (BMC) shell protein comprising one or more subunit, and (2) a first component of a specific-binding pair, operably linked to the BMC shell protein such that the first component faces (i) a lumen (inside) side, or (ii) outside of a BMC shell formed incorporating the fusion protein and the fusion protein does not disrupt or prevent the folding of the BMC shell protein or the ability of the BMC shell protein to integrate with other BMC shell proteins into a BMC shell; wherein the first component is capable of forming a stable or irreversible interaction with a second component of the specific-binding pair.